ePMA Implementation Guidance for FHIR STU3

This guidance is under active development by NHS Digital and content may be added or updated on a regular basis.
Please note: This guidance has been superseded by the Implementation guide for digitial medicines, which contains up-to-date information.

Element: isBrand

This element has been removed from FHIR R4 so should not be implemented as part of an STU3 or CareConnect implementation.

Within the dm+d terminology, medication that is a brand is identified as an AMP and AMPP concept.

back to top